-transparent.png){kind=logo}
In this work are presented results obtained in the treament of thirty patients suffering of lepromatous leprosy. In a group of fifteen patients L-tetramisol was administrated in association to antimocrobian drugs. The control group received only the last medication. Immunological modifications were not observed in any case. However, in six patients treated with L-tetramisol associated to rifampicin during three months it was possible to observe a notable improvement of the clinical state. In the patients that received L-tetramisol associated to other drugs or in those that received only antimicrobian drugs the clinical improvement was very low or null.
Related Publications
M Galmarini, and
C M Riera, and
J Ripoll, and
M A Orozco, and
J Katz
January 1980,
Leprosy in India,
M Galmarini, and
C M Riera, and
J Ripoll, and
M A Orozco, and
J Katz
July 1982,
Leprosy in India,
M Galmarini, and
C M Riera, and
J Ripoll, and
M A Orozco, and
J Katz
July 1980,
Leprosy in India,
M Galmarini, and
C M Riera, and
J Ripoll, and
M A Orozco, and
J Katz
January 1978,
British medical journal,
M Galmarini, and
C M Riera, and
J Ripoll, and
M A Orozco, and
J Katz
June 1975,
Leprosy review,
M Galmarini, and
C M Riera, and
J Ripoll, and
M A Orozco, and
J Katz
June 2005,
Leprosy review,
M Galmarini, and
C M Riera, and
J Ripoll, and
M A Orozco, and
J Katz
January 1983,
Annales de dermatologie et de venereologie,
M Galmarini, and
C M Riera, and
J Ripoll, and
M A Orozco, and
J Katz
June 2001,
International journal of dermatology,
M Galmarini, and
C M Riera, and
J Ripoll, and
M A Orozco, and
J Katz
October 2020,
The American journal of tropical medicine and hygiene,
M Galmarini, and
C M Riera, and
J Ripoll, and
M A Orozco, and
J Katz
July 2014,
Cutis,
